13F HOLDINGS REPORT
Camber Capital Management LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001654954-24-010537
Total Value
$3.6M
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 1,750,000 | $952,385 | 26.36% |
| 2 | ZIMMER BIOMET HOLDINGS INC | ZBH | 1,925,000 | $208,920 | 5.78% |
| 3 | BAXTER INTL INC | 071813109 | 5,500,000 | $183,975 | 5.09% |
| 4 | MEDTRONIC PLC | MDT | 2,250,000 | $177,098 | 4.90% |
| 5 | UNIVERSAL HLTH SVCS INC | 913903100 | 950,000 | $175,684 | 4.86% |
| 6 | GLOBUS MED INC | GMED | 2,500,000 | $171,225 | 4.74% |
| 7 | VIATRIS INC | VTRS | 15,000,000 | $159,450 | 4.41% |
| 8 | HUMANA INC | HUM | 400,000 | $149,460 | 4.14% |
| 9 | MYRIAD GENETICS INC | MYGN | 5,500,000 | $134,530 | 3.72% |
| 10 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1,150,000 | $122,740 | 3.40% |
| 11 | PTC THERAPEUTICS INC | PTCT | 3,500,000 | $107,030 | 2.96% |
| 12 | BROOKDALE SR LIVING INC | 112463104 | 15,500,000 | $105,865 | 2.93% |
| 13 | GSK PLC | GLAXF | 2,675,000 | $102,988 | 2.85% |
| 14 | BIOMARIN PHARMACEUTICAL INC | BMRN | 1,100,000 | $90,563 | 2.51% |
| 15 | SELECT MED HLDGS CORP | 81619Q105 | 2,550,000 | $89,403 | 2.47% |
| 16 | CVS HEALTH CORP | CVS | 1,500,000 | $88,590 | 2.45% |
| 17 | WALGREENS BOOTS ALLIANCE INC | 931427108 | 7,000,000 | $84,665 | 2.34% |
| 18 | PFIZER INC | PFE | 2,500,000 | $69,950 | 1.94% |
| 19 | QIAGEN NV | QGEN | 1,500,000 | $61,635 | 1.71% |
| 20 | ZIMVIE INC | 98888T107 | 3,250,000 | $59,313 | 1.64% |
| 21 | DENALI THERAPEUTICS INC | DNLI | 2,000,000 | $46,440 | 1.29% |
| 22 | PERRIGO CO PLC | PRGO | 1,520,000 | $39,034 | 1.08% |
| 23 | HERBALIFE LTD | HLF | 3,000,000 | $31,170 | 0.86% |
| 24 | ARGENX SE | ARGX | 72,000 | $30,963 | 0.86% |
| 25 | SAREPTA THERAPEUTICS INC | SRPT | 150,000 | $23,700 | 0.66% |
| 26 | BROOKDALE SR LIVING INC | 112463302 | 250,000 | $23,248 | 0.64% |
| 27 | BICYCLE THERAPEUTICS PLC | BCYC | 915,000 | $18,520 | 0.51% |
| 28 | ORASURE TECHNOLOGIES INC | OSUR | 4,250,000 | $18,105 | 0.50% |
| 29 | INOGEN INC | INGN | 2,000,000 | $16,260 | 0.45% |
| 30 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 355,000 | $15,609 | 0.43% |
| 31 | ANAPTYSBIO INC | ANABV | 500,000 | $12,530 | 0.35% |
| 32 | REPLIMUNE GROUP INC | REPL | 1,350,000 | $12,150 | 0.34% |
| 33 | EVOLENT HEALTH INC | EVH | 625,000 | $11,950 | 0.33% |
| 34 | THERAVANCE BIOPHARMA INC | TBPH | 1,000,000 | $8,480 | 0.23% |
| 35 | THE BEAUTY HEALTH COMPANY | 88331L108 | 3,500,000 | $6,720 | 0.19% |
| 36 | CUREVAC N V | N2451R105 | 550,000 | $1,870 | 0.05% |
| 37 | GENMAB A/S | GNMSF | 50,000 | $1,257 | 0.03% |